| Serial Number | 97030469 |
| Word Mark | SYNER-G BIOPHARMA GROUP |
| Filing Date | Thursday, September 16, 2021 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, May 28, 2024 |
| Registration Number | 7402522 |
| Registration Date | Tuesday, May 28, 2024 |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, August 8, 2023 |
| Description of Mark | The mark consists of a stylized pyramid with one side consisting of a solid triangle and the other side consisting of lines forming a triangle appearing to the left of the stylized word "SYNER-G" above the stylized words "BioPharma Group" with the words separated by a horizontal line. |
| Pseudo Mark | SYNERGY BIOPHARMACEUTICAL GROUP |
| Goods and Services | Providing business intelligence services in the fields of pharmaceuticals, biotechnology, and life sciences; business consulting services in the fields of pharmaceuticals and biopharmaceuticals and related technologies, specifically, business consulting with respect to clinical development, formulation, evaluation, approval, delivery, commercialization, marketing, and life-cycle management of drugs; business services, namely, formulation of best practices for drug discovery, formulation development, clinical supplies, pharmacology, toxicology, clinical supplies, and clinical development services; regulatory submission management, namely, assisting others in preparing and filing applications for new pharmaceuticals with governmental regulatory bodies |
| Goods and Services | Regulatory compliance consulting in the fields of pharmaceuticals, biotechnology, and life sciences |
| NOT AVAILABLE | "BIOPHARMA GROUP" |
| Goods and Services | Consulting services in the fields of pharmaceutical research and development, biotechnology, and life sciences; providing scientific research services in the fields of pharmaceutical design and development, pharmaceutical chemistry, pharmaceutical manufacturing and controls; consulting services regarding research and development, pharmaceutical drug formulation development, and quality control for others in the fields of pharmaceuticals, biotechnology, and life sciences; technical advisory services in the fields of pharmaceutical research and development, biotechnology, and life sciences; technical consulting in the fields of pharmaceutical research and development, biotechnology, and life sciences; technical consulting services, namely, evaluating the safety of pharmaceutical products in clinical development or in commercial production; consultation services relating to consumer software in the fields of pharmaceuticals, biotechnology, and life sciences; Consulting services for others in the field of design, planning, and implementation project management of clinical trial development and clinical trials; Providing technical consulting services in the nature of advising on the testing, analysis and evaluation of the goods of others to determine conformity with certification standards; design and development of computer software for database management in the fields of pharmaceuticals, biotechnology and life sciences; pharmaceutical drug development services; toxicology services; Scientific research consulting in the field of clinical trial development and clinical trials |
| International Class | 035 - Advertising; business management; business administration; office functions. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, October 21, 2021 |
| Primary Code | 035 |
| First Use Anywhere Date | Wednesday, October 20, 2021 |
| First Use In Commerce Date | Wednesday, October 20, 2021 |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, October 21, 2021 |
| Primary Code | 042 |
| First Use Anywhere Date | Wednesday, October 20, 2021 |
| First Use In Commerce Date | Wednesday, October 20, 2021 |
| International Class | 045 - Legal services; security services for the protection of property and individuals; personal and social services rendered by others to meet the needs of individuals. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, October 21, 2021 |
| Primary Code | 045 |
| First Use Anywhere Date | Wednesday, October 20, 2021 |
| First Use In Commerce Date | Wednesday, October 20, 2021 |
| Party Name | SYNER-G BIOPHARMA GROUP LLC |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Framingham, MA 01701 |
| Party Name | SYNER-G BIOPHARMA GROUP LLC |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Framingham, MA 01701 |
| Party Name | SYNER-G BIOPHARMA GROUP LLC |
| Party Type | 11 - New Owner Before Publication |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | SOUTHBOROUGH, MA 01772 |
| Party Name | Syner-G Pharma Consulting, LLC |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Southborough, MA 01772 |
| Event Date | Event Description |
| Monday, September 20, 2021 | NEW APPLICATION ENTERED |
| Thursday, October 21, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, October 22, 2021 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Wednesday, June 8, 2022 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
| Tuesday, June 21, 2022 | ASSIGNED TO EXAMINER |
| Tuesday, June 21, 2022 | NON-FINAL ACTION WRITTEN |
| Tuesday, June 21, 2022 | NON-FINAL ACTION E-MAILED |
| Tuesday, June 21, 2022 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, December 5, 2022 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, December 5, 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, December 6, 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, January 3, 2023 | SUSPENSION LETTER WRITTEN |
| Tuesday, January 3, 2023 | LETTER OF SUSPENSION E-MAILED |
| Tuesday, January 3, 2023 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Wednesday, July 5, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, July 19, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, August 8, 2023 | PUBLISHED FOR OPPOSITION |
| Tuesday, August 8, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, October 3, 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Thursday, October 26, 2023 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Thursday, October 26, 2023 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Thursday, October 26, 2023 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Thursday, October 26, 2023 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Thursday, October 26, 2023 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Tuesday, April 2, 2024 | TEAS STATEMENT OF USE RECEIVED |
| Tuesday, April 2, 2024 | USE AMENDMENT FILED |
| Saturday, April 20, 2024 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Saturday, April 20, 2024 | STATEMENT OF USE PROCESSING COMPLETE |
| Wednesday, April 24, 2024 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| Tuesday, May 28, 2024 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, May 28, 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Wednesday, April 24, 2024 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |